Genivent Partners reported assets under management of approximately $20.1 million for Q1 2026. The evergreen, multi-asset fund invests primarily in Omnigence partner fund secondaries and general partner interests, with current exposure to Arvore Partners and Veripath Partners.
Monthly distributions continued throughout the quarter, with the annualized normal distribution rate reaching 16.21% in March 2026. Since its first unit issuance in April 2025, Genivent has distributed approximately $0.155 per unit. Past performance is not indicative of future results, and distributions are not guaranteed.
The fund is available to accredited investors, subject to a minimum investment of $300,000 and applicable eligibility requirements.